SI - NYSE
Shoulder Innovations, Inc.
$13.83
-1.2%Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
At a Glance
Live SnapshotShoulder Innovations, Inc. Funding & Solvency Profile
Financial Health Analysis
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Shoulder Innovations, Inc. Balance Sheet
SI • NYSE
| Shoulder Innovations, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
ASSETS | |||
CURRENT ASSETS | |||
26.9M | 6.1M | 6.2M | |
78K | 8.9M | 26.6M | |
124.3M | 15M | 32.8M | |
8.3M | 5.1M | 4.7M | |
8.3M | 5.1M | 4.7M | |
21.6M | 14M | 9.9M | |
0.0 | 431K | 419K | |
3M | 573K | 0.0 | |
157.2M | 35.1M | 47.8M | |
NON-CURRENT ASSETS | |||
12.6M | 7.6M | 5.7M | |
100K | 400K | 700K | |
100K | 400K | 700K | |
12.7M | 8M | 6.4M | |
169.9M | 43.1M | 54.3M | |
LIABILITIES | |||
CURRENT LIABILITIES | |||
0.0 | 5.7M | 2.6M | |
0.0 | 4.9M | 2M | |
0.0 | 836K | 619K | |
0.0 | 1.4M | 1.4M | |
62K | 0.0 | 0.0 | |
0.0 | 47K | 43K | |
-7.8M | 0.0 | 0.0 | |
-7.8M | 554K | 228K | |
-7.8M | 7.6M | 4.3M | |
NON-CURRENT LIABILITIES | |||
15M | 14.7M | 14.4M | |
0.0 | 75.4M | 75.3M | |
15M | 90.1M | 89.7M | |
0.0 | 72K | 114K | |
15M | 97.8M | 94M | |
SHAREHOLDERS' EQUITY | |||
0.0 | 74.5M | 74.5M | |
20.6B | 1K | 1K | |
0.0 | 2.1M | 1.3M | |
0.0 | -57M | -41.4M | |
0.0 | 197K | 356K | |
154.9M | 19.8M | 34.7M | |
154.9M | -54.7M | -39.7M | |
SUMMARY | |||
169.9M | 43.1M | 54.3M | |
78K | 8.9M | 26.6M | |
15M | 14.7M | 14.5M | |
-11.8M | 8.6M | 8.2M | |
20,359,960 | 20,359,960 | 20,359,960 |
SEC Filings
SI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 13, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 14, 2026 | April 13, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 10, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 10, 2026 | March 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 03, 2025 | December 03, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your SI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.